Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
Jonker, D J, Karapetis, C S, Harbison, C, O'Callaghan, C J, Tu, D, Simes, R J, Malone, D P, Langer, C, Tebbutt, N, Price, T J, Shapiro, J, Siu, L L, Wong, R P W, Bjarnason, G, Moore, M J, Zalcberg, J R, Khambata-Ford, S
Published in British journal of cancer (04.02.2014)
Published in British journal of cancer (04.02.2014)
Get full text
Journal Article
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17
Vickers, M.M., Karapetis, C.S., Tu, D., O'Callaghan, C.J., Price, T.J., Tebbutt, N.C., Van Hazel, G., Shapiro, J.D., Pavlakis, N., Gibbs, P., Blondal, J., Lee, U., Meharchand, J.M., Burkes, R.L., Rubin, S.H., Simes, J., Zalcberg, J.R., Moore, M.J., Zhu, L., Jonker, D.J.
Published in Annals of oncology (01.04.2013)
Published in Annals of oncology (01.04.2013)
Get full text
Journal Article
Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer
Day, F L, Leong, T, Ngan, S, Thomas, R, Jefford, M, Zalcberg, J R, Rischin, D, McKendick, J, Milner, A D, Di Iulio, J, Matera, A, Michael, M
Published in British journal of cancer (18.01.2011)
Published in British journal of cancer (18.01.2011)
Get full text
Journal Article
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
Brulé, S.Y, Jonker, D.J, Karapetis, C.S, O’Callaghan, C.J, Moore, M.J, Wong, R, Tebbutt, N.C, Underhill, Cr, Yip, D, Zalcberg, J.R, Tu, D, Goodwin, R.A
Published in European journal of cancer (1990) (01.07.2015)
Published in European journal of cancer (1990) (01.07.2015)
Get full text
Journal Article
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)
Casali, P.G., Le Cesne, A., Velasco, A.P., Kotasek, D., Rutkowski, P., Hohenberger, P., Fumagalli, E., Judson, I.R., Italiano, A., Gelderblom, H., Penel, N., Hartmann, J.T., Duffaud, F., Goldstein, D., Martin-Broto, J., Gronchi, A., Wardelmann, E., Marréaud, S., Zalcberg, J.R., Litière, S., Blay, J.-Y.
Published in Annals of oncology (01.04.2021)
Published in Annals of oncology (01.04.2021)
Get full text
Journal Article
5-FLUOROURACIL: A PHARMACOLOGICAL PARADIGM IN THE USE OF CYTOTOXICS
Thomas, DM, Zalcberg, JR
Published in Clinical and experimental pharmacology & physiology (01.11.1998)
Published in Clinical and experimental pharmacology & physiology (01.11.1998)
Get full text
Journal Article
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
Barbour, A.P., Walpole, E.T., Mai, G.T., Barnes, E.H., Watson, D.I., Ackland, S.P., Martin, J.M., Burge, M., Finch, R., Karapetis, C.S., Shannon, J., Nott, L.M., Varma, S., Marx, G., Falk, G.L., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J.R., Simes, J., Smithers, B.M., Barbour, A., Simes, J., Walpole, E., Mai, T., Watson, D., Karapetis, C., Gebski, V., Barnes, L., Oostendorp, M., Wilson, K.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study
Folprecht, G., Pericay, C., Saunders, M.P., Thomas, A., Lopez Lopez, R., Roh, J.K., Chistyakov, V., Höhler, T., Kim, J.-S., Hofheinz, R.-D., Ackland, S.P., Swinson, D., Kopp, M., Udovitsa, D., Hall, M., Iveson, T., Vogel, A., Zalcberg, J.R.
Published in Annals of oncology (01.07.2016)
Published in Annals of oncology (01.07.2016)
Get full text
Journal Article
Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line
PARISOT, J. P, HU, X. F, DELUISE, M, ZALCBERG, J. R
Published in British journal of cancer (01.02.1999)
Published in British journal of cancer (01.02.1999)
Get full text
Journal Article
A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer
Michael, M, Price, T, Ngan, S Y, Ganju, V, Strickland, A H, Muller, A, Khamly, K, Milner, A D, Dilulio, J, Matera, A, Zalcberg, J R, Leong, T
Published in British journal of cancer (13.01.2009)
Published in British journal of cancer (13.01.2009)
Get full text
Journal Article
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance
KANTHARIDIS, P, EL-OSTA, A, DESILVA, M, WALL, D. M. P, HU, X. F, SLATER, A, NADALIN, G, PARKIN, J. D, ZALCBERG, J. R
Published in Clinical cancer research (01.11.1997)
Get full text
Published in Clinical cancer research (01.11.1997)
Journal Article
Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial
Mittmann, Nicole, Au, Heather-Jane, Tu, Dongsheng, O'Callaghan, Christopher J., Isogai, Pierre K., Karapetis, Christos S., Zalcberg, John R., Evans, William K., Moore, Malcolm J., Siddiqui, Jehan, Findlay, Brian, Colwell, Bruce, Simes, John, Gibbs, Peter, Links, Matthew, Tebbutt, Niall C., Jonker, Derek J.
Published in JNCI : Journal of the National Cancer Institute (02.09.2009)
Published in JNCI : Journal of the National Cancer Institute (02.09.2009)
Get full text
Journal Article
Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel +/-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma
Barbour, A.P., Walpole, E.T., Mai, G.T., Barnes, L., Watson, D.I., Ackland, S.P., Wills, V., Martin, J., Burge, M., Karapetis, C.S., Shannon, J., Nott, L.M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J.R., Simes, J., Smithers, M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer
Ferraro, D., Goldstein, D., O’Connell, R. L., Zalcberg, J. R., Sjoquist, K. M., Tebbutt, N. C., Grimison, P., McLachlan, S., Lipton, L. L., Vasey, P., Gebski, V. J., Aiken, C., Cronk, M., Ng, S., Karapetis, C. S., Shannon, J.
Published in Cancer chemotherapy and pharmacology (01.08.2016)
Published in Cancer chemotherapy and pharmacology (01.08.2016)
Get full text
Journal Article
Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780
Hu, X F, Veroni, M, De Luise, M, Wakeling, A, Sutherland, R, Watts, C K, Zalcberg, J R
Published in International journal of cancer (11.11.1993)
Published in International journal of cancer (11.11.1993)
Get more information
Journal Article